Home / Academic Researcher / Paige Prostate
Paige Prostate
Paid FEATURED

Paige Prostate

FDA-cleared AI for digital pathology and oncology.

Snapshot of Paige Prostate
Auto-generated snapshot

The first FDA-authorized AI system for pathology. It assists pathologists in identifying and segmenting cancerous tissue in prostate biopsies, helping to ensure small foci of cancer are not missed during diagnostic review.

PROS

  • + First FDA-authorized AI system for pathology
  • + High diagnostic accuracy with up to 99% sensitivity
  • + Improves pathologist productivity via case prescreening
  • + Standardizes tumor grading (Gleason score) for consistency
  • + Seamlessly integrates with existing digital pathology systems

CONS

  • - Requires significant upfront investment in digital pathology infrastructure (scanners
  • - IT)
  • - Custom enterprise pricing model makes it inaccessible for smaller labs
  • - Requires the added workflow step of digitizing slides into Whole-Slide Images (WSIs)
  • Detecting prostate cancer in whole-slide images
  • Automating Gleason pattern grading and tumor quantification
  • Prescreening and prioritizing high-suspicion pathology cases
  • Identifying perineural invasion (PNI) for prognosis
  • Providing a quality assurance second read for missed foci

SIMILAR TOOLS

Weekly Intel

STAY AHEAD OF THE AI CURVE

Join 10,000+ professionals getting curated AI tool recommendations. No fluff, just actionable value.